Global Meningococcal Vaccine Supply, Demand and Key Producers, 2024-2030

Description

The global Meningococcal Vaccine market size is expected to reach $ 359.8 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.

In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

This report studies the global Meningococcal Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Meningococcal Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meningococcal Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Meningococcal Vaccine total production and demand, 2019-2030, (10K Pcs)
Global Meningococcal Vaccine total production value, 2019-2030, (USD Million)
Global Meningococcal Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (10K Pcs)
Global Meningococcal Vaccine consumption by region & country, CAGR, 2019-2030 & (10K Pcs)
U.S. VS China: Meningococcal Vaccine domestic production, consumption, key domestic manufacturers and share
Global Meningococcal Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (10K Pcs)
Global Meningococcal Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (10K Pcs)
Global Meningococcal Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (10K Pcs).

This reports profiles key players in the global Meningococcal Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med and China National Biotec Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meningococcal Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (10K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Meningococcal Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Meningococcal Vaccine Market, Segmentation by Type
    Meningtits A
    Polysaccharide Meningtitis AC
    Meningitis ACYW

Global Meningococcal Vaccine Market, Segmentation by Application
    6 Months-15Year
    over 3 Year
    over 2 Year
    over 3 Months

Companies Profiled:
    Novartis
    GSK
    Merck
    CSL
    Baxter
    JN International Medical Corporation
    Serum Institute of India
    Bio-Med
    China National Biotec Group
    Hualan Bio
    Walvax
    Zhifei

Key Questions Answered
1. How big is the global Meningococcal Vaccine market?
2. What is the demand of the global Meningococcal Vaccine market?
3. What is the year over year growth of the global Meningococcal Vaccine market?
4. What is the production and production value of the global Meningococcal Vaccine market?
5. Who are the key producers in the global Meningococcal Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Meningococcal Vaccine Introduction
    1.2 World Meningococcal Vaccine Supply & Forecast
        1.2.1 World Meningococcal Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Meningococcal Vaccine Production (2019-2030)
        1.2.3 World Meningococcal Vaccine Pricing Trends (2019-2030)
    1.3 World Meningococcal Vaccine Production by Region (Based on Production Site)
        1.3.1 World Meningococcal Vaccine Production Value by Region (2019-2030)
        1.3.2 World Meningococcal Vaccine Production by Region (2019-2030)
        1.3.3 World Meningococcal Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Meningococcal Vaccine Production (2019-2030)
        1.3.5 Europe Meningococcal Vaccine Production (2019-2030)
        1.3.6 China Meningococcal Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Meningococcal Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Meningococcal Vaccine Major Market Trends

2 Demand Summary
    2.1 World Meningococcal Vaccine Demand (2019-2030)
    2.2 World Meningococcal Vaccine Consumption by Region
        2.2.1 World Meningococcal Vaccine Consumption by Region (2019-2024)
        2.2.2 World Meningococcal Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Meningococcal Vaccine Consumption (2019-2030)
    2.4 China Meningococcal Vaccine Consumption (2019-2030)
    2.5 Europe Meningococcal Vaccine Consumption (2019-2030)
    2.6 Japan Meningococcal Vaccine Consumption (2019-2030)
    2.7 South Korea Meningococcal Vaccine Consumption (2019-2030)
    2.8 ASEAN Meningococcal Vaccine Consumption (2019-2030)
    2.9 India Meningococcal Vaccine Consumption (2019-2030)

3 World Meningococcal Vaccine Manufacturers Competitive Analysis
    3.1 World Meningococcal Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Meningococcal Vaccine Production by Manufacturer (2019-2024)
    3.3 World Meningococcal Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Meningococcal Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Meningococcal Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Meningococcal Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Meningococcal Vaccine in 2023
    3.6 Meningococcal Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Meningococcal Vaccine Market: Region Footprint
        3.6.2 Meningococcal Vaccine Market: Company Product Type Footprint
        3.6.3 Meningococcal Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Meningococcal Vaccine Production Value Comparison
        4.1.1 United States VS China: Meningococcal Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Meningococcal Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Meningococcal Vaccine Production Comparison
        4.2.1 United States VS China: Meningococcal Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Meningococcal Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Meningococcal Vaccine Consumption Comparison
        4.3.1 United States VS China: Meningococcal Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Meningococcal Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Meningococcal Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Meningococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Meningococcal Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Meningococcal Vaccine Production (2019-2024)
    4.5 China Based Meningococcal Vaccine Manufacturers and Market Share
        4.5.1 China Based Meningococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Meningococcal Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Meningococcal Vaccine Production (2019-2024)
    4.6 Rest of World Based Meningococcal Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Meningococcal Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Meningococcal Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Meningococcal Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Meningococcal Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Meningtits A
        5.2.2 Polysaccharide Meningtitis AC
        5.2.3 Meningitis ACYW
    5.3 Market Segment by Type
        5.3.1 World Meningococcal Vaccine Production by Type (2019-2030)
        5.3.2 World Meningococcal Vaccine Production Value by Type (2019-2030)
        5.3.3 World Meningococcal Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Meningococcal Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 6 Months-15Year
        6.2.2 over 3 Year
        6.2.3 over 2 Year
        6.2.4 over 3 Months
    6.3 Market Segment by Application
        6.3.1 World Meningococcal Vaccine Production by Application (2019-2030)
        6.3.2 World Meningococcal Vaccine Production Value by Application (2019-2030)
        6.3.3 World Meningococcal Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Meningococcal Vaccine Product and Services
        7.1.4 Novartis Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 GSK
        7.2.1 GSK Details
        7.2.2 GSK Major Business
        7.2.3 GSK Meningococcal Vaccine Product and Services
        7.2.4 GSK Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 GSK Recent Developments/Updates
        7.2.6 GSK Competitive Strengths & Weaknesses
    7.3 Merck
        7.3.1 Merck Details
        7.3.2 Merck Major Business
        7.3.3 Merck Meningococcal Vaccine Product and Services
        7.3.4 Merck Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Merck Recent Developments/Updates
        7.3.6 Merck Competitive Strengths & Weaknesses
    7.4 CSL
        7.4.1 CSL Details
        7.4.2 CSL Major Business
        7.4.3 CSL Meningococcal Vaccine Product and Services
        7.4.4 CSL Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 CSL Recent Developments/Updates
        7.4.6 CSL Competitive Strengths & Weaknesses
    7.5 Baxter
        7.5.1 Baxter Details
        7.5.2 Baxter Major Business
        7.5.3 Baxter Meningococcal Vaccine Product and Services
        7.5.4 Baxter Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Baxter Recent Developments/Updates
        7.5.6 Baxter Competitive Strengths & Weaknesses
    7.6 JN International Medical Corporation
        7.6.1 JN International Medical Corporation Details
        7.6.2 JN International Medical Corporation Major Business
        7.6.3 JN International Medical Corporation Meningococcal Vaccine Product and Services
        7.6.4 JN International Medical Corporation Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 JN International Medical Corporation Recent Developments/Updates
        7.6.6 JN International Medical Corporation Competitive Strengths & Weaknesses
    7.7 Serum Institute of India
        7.7.1 Serum Institute of India Details
        7.7.2 Serum Institute of India Major Business
        7.7.3 Serum Institute of India Meningococcal Vaccine Product and Services
        7.7.4 Serum Institute of India Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Serum Institute of India Recent Developments/Updates
        7.7.6 Serum Institute of India Competitive Strengths & Weaknesses
    7.8 Bio-Med
        7.8.1 Bio-Med Details
        7.8.2 Bio-Med Major Business
        7.8.3 Bio-Med Meningococcal Vaccine Product and Services
        7.8.4 Bio-Med Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Bio-Med Recent Developments/Updates
        7.8.6 Bio-Med Competitive Strengths & Weaknesses
    7.9 China National Biotec Group
        7.9.1 China National Biotec Group Details
        7.9.2 China National Biotec Group Major Business
        7.9.3 China National Biotec Group Meningococcal Vaccine Product and Services
        7.9.4 China National Biotec Group Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 China National Biotec Group Recent Developments/Updates
        7.9.6 China National Biotec Group Competitive Strengths & Weaknesses
    7.10 Hualan Bio
        7.10.1 Hualan Bio Details
        7.10.2 Hualan Bio Major Business
        7.10.3 Hualan Bio Meningococcal Vaccine Product and Services
        7.10.4 Hualan Bio Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Hualan Bio Recent Developments/Updates
        7.10.6 Hualan Bio Competitive Strengths & Weaknesses
    7.11 Walvax
        7.11.1 Walvax Details
        7.11.2 Walvax Major Business
        7.11.3 Walvax Meningococcal Vaccine Product and Services
        7.11.4 Walvax Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Walvax Recent Developments/Updates
        7.11.6 Walvax Competitive Strengths & Weaknesses
    7.12 Zhifei
        7.12.1 Zhifei Details
        7.12.2 Zhifei Major Business
        7.12.3 Zhifei Meningococcal Vaccine Product and Services
        7.12.4 Zhifei Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Zhifei Recent Developments/Updates
        7.12.6 Zhifei Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Meningococcal Vaccine Industry Chain
    8.2 Meningococcal Vaccine Upstream Analysis
        8.2.1 Meningococcal Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Meningococcal Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Meningococcal Vaccine Production Mode
    8.6 Meningococcal Vaccine Procurement Model
    8.7 Meningococcal Vaccine Industry Sales Model and Sales Channels
        8.7.1 Meningococcal Vaccine Sales Model
        8.7.2 Meningococcal Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Meningococcal Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Meningococcal Vaccine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Meningococcal Vaccine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Meningococcal Vaccine Production Value Market Share by Region (2019-2024)
    Table 5. World Meningococcal Vaccine Production Value Market Share by Region (2025-2030)
    Table 6. World Meningococcal Vaccine Production by Region (2019-2024) & (10K Pcs)
    Table 7. World Meningococcal Vaccine Production by Region (2025-2030) & (10K Pcs)
    Table 8. World Meningococcal Vaccine Production Market Share by Region (2019-2024)
    Table 9. World Meningococcal Vaccine Production Market Share by Region (2025-2030)
    Table 10. World Meningococcal Vaccine Average Price by Region (2019-2024) & (USD/Pcs)
    Table 11. World Meningococcal Vaccine Average Price by Region (2025-2030) & (USD/Pcs)
    Table 12. Meningococcal Vaccine Major Market Trends
    Table 13. World Meningococcal Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (10K Pcs)
    Table 14. World Meningococcal Vaccine Consumption by Region (2019-2024) & (10K Pcs)
    Table 15. World Meningococcal Vaccine Consumption Forecast by Region (2025-2030) & (10K Pcs)
    Table 16. World Meningococcal Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Meningococcal Vaccine Producers in 2023
    Table 18. World Meningococcal Vaccine Production by Manufacturer (2019-2024) & (10K Pcs)
    Table 19. Production Market Share of Key Meningococcal Vaccine Producers in 2023
    Table 20. World Meningococcal Vaccine Average Price by Manufacturer (2019-2024) & (USD/Pcs)
    Table 21. Global Meningococcal Vaccine Company Evaluation Quadrant
    Table 22. World Meningococcal Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Meningococcal Vaccine Production Site of Key Manufacturer
    Table 24. Meningococcal Vaccine Market: Company Product Type Footprint
    Table 25. Meningococcal Vaccine Market: Company Product Application Footprint
    Table 26. Meningococcal Vaccine Competitive Factors
    Table 27. Meningococcal Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Meningococcal Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Meningococcal Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Meningococcal Vaccine Production Comparison, (2019 & 2023 & 2030) & (10K Pcs)
    Table 31. United States VS China Meningococcal Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (10K Pcs)
    Table 32. United States Based Meningococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Meningococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Meningococcal Vaccine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Meningococcal Vaccine Production (2019-2024) & (10K Pcs)
    Table 36. United States Based Manufacturers Meningococcal Vaccine Production Market Share (2019-2024)
    Table 37. China Based Meningococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Meningococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Meningococcal Vaccine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Meningococcal Vaccine Production (2019-2024) & (10K Pcs)
    Table 41. China Based Manufacturers Meningococcal Vaccine Production Market Share (2019-2024)
    Table 42. Rest of World Based Meningococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Meningococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Meningococcal Vaccine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Meningococcal Vaccine Production (2019-2024) & (10K Pcs)
    Table 46. Rest of World Based Manufacturers Meningococcal Vaccine Production Market Share (2019-2024)
    Table 47. World Meningococcal Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Meningococcal Vaccine Production by Type (2019-2024) & (10K Pcs)
    Table 49. World Meningococcal Vaccine Production by Type (2025-2030) & (10K Pcs)
    Table 50. World Meningococcal Vaccine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Meningococcal Vaccine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Meningococcal Vaccine Average Price by Type (2019-2024) & (USD/Pcs)
    Table 53. World Meningococcal Vaccine Average Price by Type (2025-2030) & (USD/Pcs)
    Table 54. World Meningococcal Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Meningococcal Vaccine Production by Application (2019-2024) & (10K Pcs)
    Table 56. World Meningococcal Vaccine Production by Application (2025-2030) & (10K Pcs)
    Table 57. World Meningococcal Vaccine Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Meningococcal Vaccine Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Meningococcal Vaccine Average Price by Application (2019-2024) & (USD/Pcs)
    Table 60. World Meningococcal Vaccine Average Price by Application (2025-2030) & (USD/Pcs)
    Table 61. Novartis Basic Information, Manufacturing Base and Competitors
    Table 62. Novartis Major Business
    Table 63. Novartis Meningococcal Vaccine Product and Services
    Table 64. Novartis Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Novartis Recent Developments/Updates
    Table 66. Novartis Competitive Strengths & Weaknesses
    Table 67. GSK Basic Information, Manufacturing Base and Competitors
    Table 68. GSK Major Business
    Table 69. GSK Meningococcal Vaccine Product and Services
    Table 70. GSK Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. GSK Recent Developments/Updates
    Table 72. GSK Competitive Strengths & Weaknesses
    Table 73. Merck Basic Information, Manufacturing Base and Competitors
    Table 74. Merck Major Business
    Table 75. Merck Meningococcal Vaccine Product and Services
    Table 76. Merck Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Merck Recent Developments/Updates
    Table 78. Merck Competitive Strengths & Weaknesses
    Table 79. CSL Basic Information, Manufacturing Base and Competitors
    Table 80. CSL Major Business
    Table 81. CSL Meningococcal Vaccine Product and Services
    Table 82. CSL Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. CSL Recent Developments/Updates
    Table 84. CSL Competitive Strengths & Weaknesses
    Table 85. Baxter Basic Information, Manufacturing Base and Competitors
    Table 86. Baxter Major Business
    Table 87. Baxter Meningococcal Vaccine Product and Services
    Table 88. Baxter Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Baxter Recent Developments/Updates
    Table 90. Baxter Competitive Strengths & Weaknesses
    Table 91. JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
    Table 92. JN International Medical Corporation Major Business
    Table 93. JN International Medical Corporation Meningococcal Vaccine Product and Services
    Table 94. JN International Medical Corporation Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. JN International Medical Corporation Recent Developments/Updates
    Table 96. JN International Medical Corporation Competitive Strengths & Weaknesses
    Table 97. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 98. Serum Institute of India Major Business
    Table 99. Serum Institute of India Meningococcal Vaccine Product and Services
    Table 100. Serum Institute of India Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Serum Institute of India Recent Developments/Updates
    Table 102. Serum Institute of India Competitive Strengths & Weaknesses
    Table 103. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 104. Bio-Med Major Business
    Table 105. Bio-Med Meningococcal Vaccine Product and Services
    Table 106. Bio-Med Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Bio-Med Recent Developments/Updates
    Table 108. Bio-Med Competitive Strengths & Weaknesses
    Table 109. China National Biotec Group Basic Information, Manufacturing Base and Competitors
    Table 110. China National Biotec Group Major Business
    Table 111. China National Biotec Group Meningococcal Vaccine Product and Services
    Table 112. China National Biotec Group Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. China National Biotec Group Recent Developments/Updates
    Table 114. China National Biotec Group Competitive Strengths & Weaknesses
    Table 115. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 116. Hualan Bio Major Business
    Table 117. Hualan Bio Meningococcal Vaccine Product and Services
    Table 118. Hualan Bio Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Hualan Bio Recent Developments/Updates
    Table 120. Hualan Bio Competitive Strengths & Weaknesses
    Table 121. Walvax Basic Information, Manufacturing Base and Competitors
    Table 122. Walvax Major Business
    Table 123. Walvax Meningococcal Vaccine Product and Services
    Table 124. Walvax Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Walvax Recent Developments/Updates
    Table 126. Zhifei Basic Information, Manufacturing Base and Competitors
    Table 127. Zhifei Major Business
    Table 128. Zhifei Meningococcal Vaccine Product and Services
    Table 129. Zhifei Meningococcal Vaccine Production (10K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 130. Global Key Players of Meningococcal Vaccine Upstream (Raw Materials)
    Table 131. Meningococcal Vaccine Typical Customers
    Table 132. Meningococcal Vaccine Typical Distributors
List of Figure
    Figure 1. Meningococcal Vaccine Picture
    Figure 2. World Meningococcal Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Meningococcal Vaccine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Meningococcal Vaccine Production (2019-2030) & (10K Pcs)
    Figure 5. World Meningococcal Vaccine Average Price (2019-2030) & (USD/Pcs)
    Figure 6. World Meningococcal Vaccine Production Value Market Share by Region (2019-2030)
    Figure 7. World Meningococcal Vaccine Production Market Share by Region (2019-2030)
    Figure 8. North America Meningococcal Vaccine Production (2019-2030) & (10K Pcs)
    Figure 9. Europe Meningococcal Vaccine Production (2019-2030) & (10K Pcs)
    Figure 10. China Meningococcal Vaccine Production (2019-2030) & (10K Pcs)
    Figure 11. Meningococcal Vaccine Market Drivers
    Figure 12. Factors Affecting Demand
    Figure 13. World Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 14. World Meningococcal Vaccine Consumption Market Share by Region (2019-2030)
    Figure 15. United States Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 16. China Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 17. Europe Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 18. Japan Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 19. South Korea Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 20. ASEAN Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 21. India Meningococcal Vaccine Consumption (2019-2030) & (10K Pcs)
    Figure 22. Producer Shipments of Meningococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 23. Global Four-firm Concentration Ratios (CR4) for Meningococcal Vaccine Markets in 2023
    Figure 24. Global Four-firm Concentration Ratios (CR8) for Meningococcal Vaccine Markets in 2023
    Figure 25. United States VS China: Meningococcal Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 26. United States VS China: Meningococcal Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Meningococcal Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States Based Manufacturers Meningococcal Vaccine Production Market Share 2023
    Figure 29. China Based Manufacturers Meningococcal Vaccine Production Market Share 2023
    Figure 30. Rest of World Based Manufacturers Meningococcal Vaccine Production Market Share 2023
    Figure 31. World Meningococcal Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 32. World Meningococcal Vaccine Production Value Market Share by Type in 2023
    Figure 33. Meningtits A
    Figure 34. Polysaccharide Meningtitis AC
    Figure 35. Meningitis ACYW
    Figure 36. World Meningococcal Vaccine Production Market Share by Type (2019-2030)
    Figure 37. World Meningococcal Vaccine Production Value Market Share by Type (2019-2030)
    Figure 38. World Meningococcal Vaccine Average Price by Type (2019-2030) & (USD/Pcs)
    Figure 39. World Meningococcal Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Meningococcal Vaccine Production Value Market Share by Application in 2023
    Figure 41. 6 Months-15Year
    Figure 42. over 3 Year
    Figure 43. over 2 Year
    Figure 44. over 3 Months
    Figure 45. World Meningococcal Vaccine Production Market Share by Application (2019-2030)
    Figure 46. World Meningococcal Vaccine Production Value Market Share by Application (2019-2030)
    Figure 47. World Meningococcal Vaccine Average Price by Application (2019-2030) & (USD/Pcs)
    Figure 48. Meningococcal Vaccine Industry Chain
    Figure 49. Meningococcal Vaccine Procurement Model
    Figure 50. Meningococcal Vaccine Sales Model
    Figure 51. Meningococcal Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Companies Mentioned

Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei